We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPTM icon
351
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$343K 0.01%
5,051
+435
+9% +$31.1K
MBB icon
352
iShares MBS ETF
MBB
$39.1B
$335K 0.01%
3,575
+493
+16% +$45.6K
DUK icon
353
Duke Energy
DUK
$97.3B
$322K 0.01%
2,643
-881
-25% -$100K
MU icon
354
Micron Technology
MU
$991B
$321K 0.01%
3,695
-68
-2% -$6.53K
IEF icon
355
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$318K 0.01%
3,332
-24
-0.7% -$2.25K
GE icon
356
GE Aerospace
GE
$384B
$315K 0.01%
1,575
COF icon
357
Capital One
COF
$134B
$300K 0.01%
1,673
-7
-0.4% -$1.32K
BLD
358
DELISTED
TopBuild
BLD
$299K 0.01%
979
WMS icon
359
Advanced Drainage Systems
WMS
$10.9B
$298K 0.01%
2,747
+649
+31% +$75.7K
RRX icon
360
Regal Rexnord
RRX
$11.9B
$287K 0.01%
2,525
-522
-17% -$72.5K
MNST icon
361
Monster Beverage
MNST
$88.5B
$283K 0.01%
4,835
+682
+16% +$35.5K
QQQ icon
362
Invesco QQQ Trust
QQQ
$484B
$280K 0.01%
+597
New +$303K
AMAT icon
363
Applied Materials
AMAT
$428B
$275K 0.01%
1,897
-707
-27% -$119K
GLD icon
364
SPDR Gold Trust
GLD
$141B
$275K 0.01%
953
GILD icon
365
Gilead Sciences
GILD
$165B
$274K 0.01%
2,449
-2
-0.1% -$206
USVN icon
366
US Treasury 7 Year Note ETF
USVN
$7.07M
$268K 0.01%
5,551
-343
-6% -$16.3K
TXRH icon
367
Texas Roadhouse
TXRH
$13.7B
$267K 0.01%
1,601
-20
-1% -$3.54K
GUNR icon
368
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.32B
$265K 0.01%
6,831
RWR icon
369
State Street SPDR Dow Jones REIT ETF
RWR
$1.97B
$259K 0.01%
2,611
UTRE icon
370
US Treasury 3 Year Note ETF
UTRE
$9.06M
$252K 0.01%
5,093
ENTG icon
371
Entegris
ENTG
$23.2B
$252K 0.01%
2,882
HIMS icon
372
Hims & Hers Health
HIMS
$7.31B
$248K 0.01%
8,409
-643
-7% -$23.9K
XLU icon
373
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$245K 0.01%
6,208
CRL icon
374
Charles River Laboratories
CRL
$12.8B
$240K 0.01%
1,593
-364
-19% -$61K
NVS icon
375
Novartis
NVS
$297B
$240K 0.01%
2,150

Similar funds

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.